Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|1|102-107

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.1, 2016-02, pp. : 102-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs of Abuse-Induced Hyperthermia, Blood-Brain Barrier Dysfunction and Neurotoxicity: Neuroprotective Effects of a New Antioxidant Compound H-290/51

By  

Current Pharmaceutical Design, Vol. 13, Iss. 18, 2007-06 ,pp. : 1903-1923

Bentham Science Publishers

Access to resources Recommend Favorite

GPE and GPE Analogues as Promising Neuroprotective Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 1, 2012-01 ,pp. : 13-23

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Effects of Lutein in the Retina

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 51-56

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective effects of Ginkgo biloba constituents

By Krieglstein J.   Ausmeier F.   El-Abhar H.   Lippert K.   Welsch M.   Rupalla K.   Henrich-Noack P.  

European Journal of Pharmaceutical Sciences, Vol. 3, Iss. 1, 1995-02 ,pp. : 39-48

Elsevier

Access to resources Recommend Favorite

Neuroprotective effects of nicergoline in immortalized neurons

By Sortino M.A.   Battaglia A.   Pamparana F.   Carfagna N.   Post C.   Canonico P.L.  

European Journal of Pharmacology, Vol. 368, Iss. 2, 1999-03 ,pp. : 285-290

Elsevier

Access to resources Recommend Favorite